WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+4.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$6.82B
AUM Growth
+$779M
(+13%)
Cap. Flow
+$725M
Cap. Flow
% of AUM
10.62%
Top 10 Holdings %
Top 10 Hldgs %
15.75%
Holding
877
New
205
Increased
123
Reduced
98
Closed
183
Top Buys
| 1 |
Qorvo
QRVO
|
$151M |
| 2 |
ASML
ASML
|
$118M |
| 3 |
Revolution Medicines
RVMD
|
$51.9M |
| 4 |
Intuitive Surgical
ISRG
|
$50.7M |
| 5 |
Meta Platforms (Facebook)
META
|
$50.2M |
Top Sells
| 1 |
Teradyne
TER
|
$132M |
| 2 |
Qualcomm
QCOM
|
$77.3M |
| 3 |
KLA
KLAC
|
$70.4M |
| 4 |
Abbott
ABT
|
$69.2M |
| 5 |
Booking.com
BKNG
|
$67.7M |
Sector Composition
| 1 | Healthcare | 42.14% |
| 2 | Technology | 30.14% |
| 3 | Communication Services | 6.89% |
| 4 | Industrials | 6.58% |
| 5 | Financials | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Relay Therapeutics
RLAY
$710M
| $7.85M | 0.11% |
255,601
| – | – |
|
227
United Therapeutics
UTHR
$18.1B
| $7.82M | 0.11% |
+36,211
| New | +$7.82M |
|
|
CERE
228
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $7.69M | 0.11% |
237,326
+41,995
| +21% | +$1.36M |
|
229
iHeartMedia
IHRT
$315M
| $7.58M | 0.11% |
+360,453
| New | +$7.58M |
|
230
Dave Inc
DAVE
$2.63B
| $7.5M | 0.11% |
23,438
| – | – |
|
231
Sana Biotechnology
SANA
$752M
| $7.47M | 0.11% |
482,706
+62,839
| +15% | +$973K |
|
232
System1
SST
$62.5M
| $7.47M | 0.11% |
75,000
| – | – |
|
233
Allogene Therapeutics
ALLO
$246M
| $7.46M | 0.11% |
500,095
-312,635
| -38% | -$4.66M |
|
|
GCAC
234
DELISTED
Growth Capital Acquisition Corp. Class A Common Stock
GCAC
| $7.45M | 0.11% |
750,000
| – | – |
|
235
Infosys
INFY
$67.9B
| $7.44M | 0.11% |
294,075
-235,819
| -45% | -$5.97M |
|
236
Samsara
IOT
$24B
| $7.42M | 0.11% |
+263,819
| New | +$7.42M |
|
237
AlTi Global
ALTI
$432M
| $7.41M | 0.11% |
749,999
+300,000
| +67% | +$2.96M |
|
238
Seer Inc
SEER
$118M
| $7.4M | 0.11% |
324,180
+95,365
| +42% | +$2.18M |
|
239
Merus
MRUS
$5.1B
| $7.37M | 0.11% |
+231,737
| New | +$7.37M |
|
240
Cullinan Oncology
CGEM
$413M
| $7.33M | 0.11% |
475,058
| – | – |
|
|
RACB
241
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $7.29M | 0.1% |
750,000
| – | – |
|
|
AUS
242
DELISTED
Austerlitz Acquisition Corporation I
AUS
| $7.28M | 0.1% |
750,000
| – | – |
|
|
ANSS
243
DELISTED
Ansys
ANSS
| $7.28M | 0.1% |
+18,146
| New | +$7.28M |
|
244
Workday
WDAY
$61.7B
| $6.97M | 0.1% |
25,508
-74,684
| -75% | -$20.4M |
|
245
Nerdy
NRDY
$163M
| $6.91M | 0.1% |
1,536,171
-50,155
| -3% | -$226K |
|
246
PMV Pharmaceuticals
PMVP
$77.4M
| $6.9M | 0.1% |
298,610
-108,755
| -27% | -$2.51M |
|
247
Syndax Pharmaceuticals
SNDX
$1.47B
| $6.79M | 0.1% |
310,377
-270,931
| -47% | -$5.93M |
|
|
BPMC
248
DELISTED
Blueprint Medicines
BPMC
| $6.65M | 0.1% |
62,055
-109,980
| -64% | -$11.8M |
|
249
Nu Holdings
NU
$71.2B
| $6.64M | 0.1% |
+708,311
| New | +$6.64M |
|
250
Option Care Health
OPCH
$4.72B
| $6.63M | 0.09% |
232,958
+165,188
| +244% | +$4.7M |
|